🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Winners of 2022 Annual Open Grants announced! See: ardf-online.org/ardf-grants.ht… Congratulations to winners and thanks to all who applied and our EXCELLENT reviewers!

Check out this #protocol by Dr Cristina Scielzo Cristina Scielzo LAB for the generation of 3D #bonemarrow #surrogate microenvironment for chronic lymphocytic #leukemia and multiple #myeloma: star-protocols.cell.com/protocols/1888 👉Can efficiently recapitulate tumor-stroma crosstalk 👉Allows drug testing

⏱ Don't miss your chance to submit to our collection on "Advances in Therapy for Chronic Lymphocytic Leukemia"! Submit here ➡ fro.ntiers.in/csiA 👩‍⚕️👨‍⚕️ Lydia Scarfò, Toby Eyre & Lindsey Roeker #CLLsm #LEUsm #Leukemia #HemOnc

Anche quest'anno, sostieni la ricerca con dolcezza: non perdere l'appuntamento con i #CioccolatiniDellaRicerca. #OggiCambiamoIlDomani #airc Scopri dove trovare i cioccolatini ➡ bit.ly/3UbCSOX Amazon.it BancoBPM Vignetta di EKRA

Great collaboration on ibrutinib resistance in CLL now published online in Blood Advances ashpublications.org/bloodadvances/…

PYK2 is overexpressed in chronic lymphocytic leukaemia: A potential new therapeutic target onlinelibrary.wiley.com/doi/full/10.11…

Design of a novel bioink suitable for the 3D printing of lymphoid cells frontiersin.org/articles/10.33…

Looking for the latest advances in #CLL? Join us at #iwCLL2023 in Boston on October 6-9 or follow the discussion iwCLL iwCLL2023.org.

Abstracts for #iwCLL2023 are due by May 31st! This year's event is taking place October 6-9, 2023 in Boston, MA. Click here to submit your abstract: bit.ly/3LLcAS3 For additional program details & updates, visit IWCLL2023.ORG.

#Additive #manufacturing in #healthcare: from #3dprinting to #bioprinting Five-days #school on #Lake #Como to get an insight into 3d (bio)printing for #lifescience! Few seats are still available For more info lakecomoschool.org

👀Our most-viewed article in 2023 (so far!) is an Original Research paper, co-authored by Specialty Chief Editor Prof. Silvia Fare, exploring the design and characterization of a novel bioink for 3D printing of lymphoid cells. Read the full article: 🔗fro.ntiers.in/6WLk

The Nanomechanical Properties of CLL Cells Are Linked to... : HemaSphere journals.lww.com/hemasphere/Ful… Happy to share our paper on CLL cells mechanical properties. Thank you very much to the team, this is a truly interdisciplinary effort!!!

If you are interested in using 3D models for hematologic cancers check out our latest review! Emerging Strategies in 3D Culture Models for Hematological... : HemaSphere journals.lww.com/hemasphere/Ful…

Available now — Visit iwCLL2023.org to view accepted abstracts! Late-breaker abstracts will be announced in September. There's still time to register. Click here to join us in Boston this October: loom.ly/KEbe1uc #CLL #CME #iwCLL2023

💡D Barozzi & C Scielzo explore different 3D culture approaches in use for hematologic cancer, & in parallel point out the complexity of the #microenvironment that we need to recapitulate #InVitro. Read more👉bit.ly/3KQtnlI #3Dmodels #cancerresearch Cristina Scielzo LAB

Authors show correlation between mechanical properties of B lymph cells & actomyosin cortex organization. Ibrutinib restores the physiological mechanical properties of CLL cells until onset of resistance.  👉mtr.cool/bxncuyaomt

Apply, apply! Our lab hosts one of these PhD positions ❤️‍🔥 Happy to discuss our project in more detail with anyone interested 😊

Cristina Scielzo (Cristina Scielzo LAB) spoke with us at #ERIC2024 on optimizing in vitro models of CLL and their potential to progress treatment. #CLLsm #Leusm #Leukemia #HemOnc

Join us for our 12th #ibiTea on Nov 21, 2024!☕ Meet 1⃣Dr. Cristina Scielzo Cristina Scielzo LAB from Ospedale San Raffaele & 2⃣Dr. Gianluca Cidonio Gianluca Cidonio from Sapienza Università di Roma as they share insights into #3Dbioprinting advancements. 🔗zurl.co/CIRJ #innovation #technology